Kendall Reiter
Family · Denison, TXNPI 1417699943
Payments from drug & device makers
What this record shows
26 manufacturers reported payments, led by Novartis at 25.8% of the total. Reporting peaked in 2023 at $3,590 and has fallen 65.7% since, to $1,231 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 138 payments — averaging $48.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Boston Scientific$2K
- Janssen Research & Development, LLC$1K
- AstraZeneca$470
- Merck$264
- Regeneron Healthcare Solutions, Inc.$240
- plus $1K from 20 others
What the payments were for
- Travel & lodging$2,96944%
- Food & beverage$3,70956%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 21 | $1,725 |
| Boston Scientific | 6 | $1,555 |
| Janssen Research & Development, LLC | 8 | $1,319 |
| AstraZeneca | 15 | $470 |
| Merck | 15 | $264 |
| Regeneron Healthcare Solutions, Inc. | 16 | $240 |
| Grifols USA, LLC | 10 | $152 |
| Amgen | 8 | $137 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $102 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $86 |
| Pfizer | 1 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Heartflow, Inc. | 1 | $70 |
| Scpharmaceuticals Inc. | 3 | $66 |
| Sanofi | 2 | $58 |
| Johnson & Johnson | 2 | $42 |
| GSK | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Organon | 3 | $30 |
| Biosense Webster, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Genentech USA, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Blueprint Medicines Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$1,489
- LEQVIO$1,400
- FASENRA$181
How this compares
$6,678 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Other family in Denison
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.